Does PolyPid Ltd. (PYPD) Have the Potential to Rally 166% as Wall Street Analysts Expect?Zacks Investment Research • 11/16/21
PolyPid's (PYPD) CEO Amir Weisberg on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
PolyPid Ltd. Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/10/21
PolyPid to Report Third Quarter 2021 Financial Results and Operational Highlights on November 10, 2021GlobeNewsWire • 11/01/21
PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain CancerGlobeNewsWire • 09/13/21
PolyPid Ltd's (PYPD) CEO Amir Weisberg on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/11/21
5 Outstanding Stocks to Buy That Trade Below $10 and Have Huge Upside Potential24/7 Wall Street • 08/07/21
PolyPid Presents today at The Raymond James Human Health Innovation ConferenceGlobeNewsWire • 06/23/21
PolyPid's Single Pivotal Study Sufficient To Support Potential Approval Of D-PLEX100 For Infections After Colorectal SurgeryBenzinga • 05/19/21
PolyPid's (PYPD) CEO Amir Weisberg on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/21
PolyPid Ltd. Reports First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/12/21
PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional InfectionsGlobeNewsWire • 02/16/21
PolyPid Ltd. Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial ResultsGlobeNewsWire • 02/10/21
PolyPid to Report Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights on February 10, 2021GlobeNewsWire • 01/27/21
PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy ProgramGlobeNewsWire • 12/22/20
PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional InfectionsGlobeNewsWire • 12/16/20
PolyPid to Host Key Opinion Leader Call Discussing D-PLEX₁₀₀ and the Prevention of Surgical Site InfectionsGlobeNewsWire • 12/03/20
PolyPid Granted Breakthrough Therapy Designation from FDA for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Colorectal SurgeryGlobeNewsWire • 11/24/20
PolyPid Ltd. (PYPD) CEO Amir Weisberg on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
PolyPid Ltd. Provides Corporate Update and Reports Third Quarter 2020 Financial ResultsGlobeNewsWire • 11/11/20